The largest database of trusted experimental protocols

6 protocols using o phenylenediamine tablets

1

SARS-CoV-2 Antibody Detection by ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
A semi-quantitative in vitro determination of human IgG and IgA antibodies against the SARS-CoV-2 was performed on serum samples by using the Anti-SARS-CoV-2 Spike ELISA (EUROIMMUN), according to the manufacturer’s instructions. Values were then normalized for comparison with a calibrator. Results were evaluated by calculating the ratio between the extinction of samples and the extinction of the calibrator. Results are reported as the ratio between OD sample and OD calibrator. The ratio interpretation was as follows: < 0.8 = negative, ≥ 0.8 to < 1.1 = borderline, ≥ 1.1 = positive. To detect IgM anti-RBD we developed an in-house ELISA [17 (link)]. 96-well plates (Corning) were coated for 1 h at 37 °C with 1 μg/mL of purified SARS-CoV-2 RBD protein (Sino Biological). After washing with PBS 1 × /0.05% Tween and blocking with PBS 1 × /1% BSA, plates were incubated for 1 h at 37 °C with diluted sera (1:100). After washing again, plates were incubated for 1 h at 37 °C with peroxidase-conjugated goat anti-human IgM antibody (Jacksons ImmunoResearch Laboratories). The assay was developed with o-phenylenediamine tablets (Sigma-Aldrich) as a chromogen substrate. Absorbance at 450 nm was measured, and IgM concentrations were calculated by interpolation from the standard curve based on serial dilutions of monoclonal human IgM antibody against SARS-CoV-2 Spike-RBD (Invivogen).
+ Open protocol
+ Expand
2

Immunogenicity Testing of Biotinylated Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 30 sera were selected to be tested with each peptide. Of these, 23 were from pre-exposed people with high IgM levels for Pap31 or SCS-α (accordingly to the peptide to be tested), 2 from patients with Carrión’s disease, and 5 that had no reactivity to Pap31 or SCS-α. To determine the immunogenicity of each peptide, ELISA tests were carried out using the synthetic biotinylated peptides as an antigen. Briefly, 96-well Nunc-Immuno Maxisorp microtiter plates (Nalgene Nunc International, Roskilde, Denmark) were coated with 100 μL (0.67 μg/well) of NeutrAvidin biotin-binding protein (Invitrogen, Carlsbad, CA, USA) overnight at 4 °C. After washing with phosphate-buffered saline (PBS) 0.1% Tween-20, 100 μL of a single biotinylated peptide (28.6 μg/mL in each well) was added and incubated for 1 h. The plates were washed 3 times, and sera diluted 1:100 with TBS-Tween with 1% BSA were incubated for 2 h. The same negative control and secondary antibody used in the Western blottings were used here. The optical densities were measured as absorbance at 450 nm after using o-phenylenediamine tablets as substrate (Sigma, St. Louis, MO, USA). Each sample was analyzed in triplicate intra-plate.
+ Open protocol
+ Expand
3

Synthetic Clay Mineral Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three types of clay were supplied from the Clay Mineral Society Source Clays Repository: kaolinite, Warren County, Georgia, USA (KGa-2); Na-rich montmorillonite, Crook County, Wyoming, USA (SWy-2); and Ca-rich montmorillonite, Gonzales County, Texas, USA (STx-1b). NX-illite was obtained from Arginotec, NX Nanopowder, B + M Notenkämper, Munich, Germany. NX-Illite is composed of illite, illite-smectite mixed layer, feldspar, kaolinite, quartz and carbonate52 (link).
PEG 8 kDa, dextran 10 kDa, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), HEPES sodium salt, sodium bicarbonate, o-phenylenediamine tablets, hydrogen peroxide and 2,3-diaminophenazine were purchased from Sigma-Aldrich (St. Louis, MO). Labeled polymer mPEG-NH2 MW 5000 was purchased from Shearwater Polymers. Alexa Fluor 647-dextran 10 kDa, Alexa Fluor 488 labeling kits and 20 mm diameter by 0.5 mm deep press-to-seal silicone isolators were obtained from Life Technologies (Carlsbad, CA). Water was deionized to a resistance of 18.2 MΩ with Barnstead NANOpure Diamond water purification system (Van Nuys, CA) and used for all experiments.
+ Open protocol
+ Expand
4

Immunogenic Regions of Pap31 and SCS-α

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed to determine the immunogenic region of Pap31 and SCS-α. Both the purified complete proteins and their respective 3 truncated constructs were electrophoresed on 15% SDS-PAGE gels and electrotransferred onto a PVDF membrane (GE Healthcare, Buckinghamshire, UK) using a Bio-Rad Trans-Blot SD Cell apparatus. A blocking step for 1 h at room temperature using 5% skim milk in PBS was performed. The membranes were immunoblotted during 90 min with sera (1:50 dilution in Tris-buffered saline [TBS]-Tween with 1% bovine serum albumin [BSA]). Western blottings with at least 10 sera from exposed people were performed for both Pap31 and SCS-α. A commercial negative control (DAKO X0939) consisting of a pool of at least 30 sera from healthy blood donors was used. After washing 3 times with TBS-0.05% Tween20) for10 min, the membranes were incubated for 1 h with a polyclonal rabbit anti-human IgM 1:1000 dilution in TBS-T with 1% BSA conjugated with peroxidase (Dako, Glostrup, Denmark) using o-phenylenediamine tablets as substrate (Sigma, St. Louis, MO, USA).
+ Open protocol
+ Expand
5

Quantifying Antibodies in Infant Saliva and Breastmilk

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total IgG and IgA antibodies were detected in both neonatal saliva and breastmilk samples by ELISA. In brief, 96-well plates were coated for 1 hour at room temperature with purified goat anti-human IgG or IgA antibodies (Jackson ImmunoResearch Laboratories). After washing with phosphate-buffered saline (PBS; final strength, 1×) containing 0.05% Tween and blocking with PBS (1×) containing 1% bovine serum albumin, plates were incubated for 1 hour with diluted saliva (1:100) or breastmilk (1:100) samples. Secondary antibodies were peroxidase-conjugated F(ab)2 fragments of goat anti-human IgG or IgA antibodies (Jackson ImmunoResearch Laboratories). The assay was developed with o-phenylenediamine tablets (Sigma-Aldrich). Optical density was measured using a microtiter plate reader at a wavelength of 450 nm, and immunoglobulin concentrations were calculated by interpolation with a standard curve based on serial dilutions of monoclonal human IgG or IgA antibodies (Jackson ImmunoResearch Laboratories).
+ Open protocol
+ Expand
6

Quantitative ELISA for Alpha-1 Antitrypsin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immuno Plates (Fisher Scientific International, Inc, Pittsburgh, PA, USA) were coated with 50 µL goat anti-human alpha-1 antitrypsin antibody (Table S1) at 4 °C overnight. The plate was washed three times with 1× PBST (phosphate buffered saline with 0.05% Tween-20) and then blocked with 100 µL 3% bovine serum albumin (BSA) (Sigma-Aldrich, St. Louis, MO, USA) for 1 h. After blocking, 50 µL samples were loaded in triplicate wells and incubated for 1 h at 37 °C. After washing with 1× PBST, the rabbit anti-human alpha 1-antitrypsin antibody (Table S1) was added and incubated for 1 h at 37 °C and then washed three times with 1× PBST. Goat-anti rabbit HRP antibody (Table S1) was added to the wells and incubated at 37 °C for 1 h. After a final wash with 1× PBST, o-phenylenediamine tablets (Sigma-Aldrich, St. Louis, MO, USA) were dissolved in ddH2O and 50 μL solutions were added to the wells to develop color. H2SO4 (10%, Sigma-Aldrich, St. Louis, MO, USA) was added to terminate color development. The absorbance was measured at a wavelength of 490 nm in an ELISA plate reader (Molecular Devices, LLC, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!